Vetnostrum Animal Health Co., Ltd. (TPE:6936)
Taiwan · Delayed Price · Currency is TWD 32.40
0.00 (0.00%)
Aug 26, 2026, 1:30 PM CST
Vetnostrum Animal Health Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 1,492 | 1,416 | 1,294 | 1,208 | 1,185 | |
Revenue Growth | 10.14% | 9.43% | 7.17% | 1.87% | - |
Cost of Revenue | 973.05 | 964.25 | 853.42 | 850.75 | 832.13 |
Gross Profit | 518.88 | 451.87 | 440.69 | 356.76 | 353.23 |
Selling, General & Admin | 264.1 | 238.83 | 241.18 | 219.87 | 209.09 |
Research & Development | 39.15 | 34.38 | 28.78 | 25.46 | 19.51 |
Other Operating Expenses | 22.54 | 22.54 | - | - | - |
Operating Expenses | 325.79 | 295.75 | 269.96 | 245.22 | 228.61 |
Operating Income | 193.1 | 156.12 | 170.73 | 111.54 | 124.62 |
Interest Expense | -0.4 | -0.56 | -1.1 | -1.97 | -2.92 |
Interest & Investment Income | 6.44 | 3.17 | 0.65 | 0.54 | 0.14 |
Currency Exchange Gain (Loss) | 10.23 | 4.19 | 0.87 | - | - |
Other Non Operating Income (Expenses) | 0.43 | 0.27 | 0.45 | 2.92 | 9.18 |
EBT Excluding Unusual Items | 209.79 | 163.19 | 171.6 | 113.03 | 131.01 |
Gain (Loss) on Sale of Investments | -9.7 | -3.66 | - | - | - |
Gain (Loss) on Sale of Assets | -0.15 | -0.15 | -1.89 | - | - |
Other Unusual Items | 0 | 0 | - | - | - |
Pretax Income | 199.95 | 159.39 | 169.72 | 113.03 | 131.01 |
Income Tax Expense | 38.32 | 30.54 | 33.1 | 21.43 | 24.5 |
Net Income | 161.63 | 128.85 | 136.62 | 91.6 | 106.52 |
Net Income to Common | 161.63 | 128.85 | 136.62 | 91.6 | 106.52 |
Net Income Growth | 25.88% | -5.68% | 49.15% | -14.01% | - |
Shares Outstanding (Basic) | 73 | 71 | 66 | 66 | 63 |
Shares Outstanding (Diluted) | 73 | 71 | 66 | 66 | 63 |
Shares Change | 7.89% | 6.69% | 0.09% | 4.69% | - |
EPS (Basic) | 2.22 | 1.82 | 2.06 | 1.38 | 1.69 |
EPS (Diluted) | 2.22 | 1.82 | 2.06 | 1.38 | 1.68 |
EPS Growth | 16.69% | -11.65% | 49.28% | -17.86% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 261.15 | 263.28 | 150.19 | 220 | 105.51 |
Free Cash Flow Per Share | 3.58 | 3.71 | 2.26 | 3.31 | 1.66 |
Dividend Per Share | 1.510 | 1.510 | 1.687 | 1.040 | - |
Dividend Growth | -10.48% | -10.48% | 62.19% | - | - |
Gross Margin | 34.78% | 31.91% | 34.05% | 29.54% | 29.80% |
Operating Margin | 12.94% | 11.03% | 13.19% | 9.24% | 10.51% |
Profit Margin | 10.83% | 9.10% | 10.56% | 7.59% | 8.99% |
Free Cash Flow Margin | 17.50% | 18.59% | 11.61% | 18.22% | 8.90% |
EBITDA | 253.21 | 218.09 | 236.82 | 188.28 | 202.84 |
EBITDA Margin | 16.97% | 15.40% | 18.30% | 15.59% | 17.11% |
D&A For EBITDA | 60.12 | 61.97 | 66.09 | 76.74 | 78.22 |
EBIT | 193.1 | 156.12 | 170.73 | 111.54 | 124.62 |
EBIT Margin | 12.94% | 11.03% | 13.19% | 9.24% | 10.51% |
Effective Tax Rate | 19.16% | 19.16% | 19.50% | 18.96% | 18.70% |
Advertising Expenses | - | 31.29 | - | - | - |